Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Oct 2019 07:00

RNS Number : 5770O
Assura PLC
03 October 2019
 

3 October 2019

Assura plc

 

Trading Update

For the first half of the year to 30 September 2019

 

Assura's high-quality portfolio further enhanced; GPI acquisition successfully integrated

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2019.

 

Jonathan Murphy, CEO, said:

"Assura has had a very active first six months of the reporting year as we continue to build on our strong progress. The acquisition of GPI, announced in May this year, has been integrated into Assura successfully, and further strengthens our market-leading position, putting us in a better place to provide GPs with the real estate that they need to help alleviate the stresses in the NHS.

 

"We remain confident in our outlook for the year and look forward to sharing a fuller update at our interim results in November."

 

Continued improvement to strong portfolio, supported by GPI acquisition

·; Current portfolio of 560 properties.

·; Two developments completed (Darley Dale & South Woodham Ferrers) at a cost of £8.4 million and five moved to on site (Canterbury, St Leonards, Hereford, Launceston and Bournville); total of 14 developments on site at the period end with a total development cost of £69 million.

·; Nine acquisitions completed in the period at a cost of £34.3 million.

·; 14 disposals completed for £18 million cash consideration at a small premium to book value at March 2019.

 

Strong development pipeline offers significant opportunity

·; Immediate development pipeline of £72 million.

·; Immediate acquisitions pipeline of £65 million, compared with £41 million at March 2019.

·; Total immediate pipeline, including on site developments, worth £206 million, up from £142 million at year end.

 

Continued rent roll growth

·; 13 lease re-gears agreed on £0.9 million of rent, adding weighted average of 8.5 years WAULT to those leases.

·; Annualised rent roll at £104.4 million taking account of additions, disposals and rent reviews.

 

Strong financials provide solid platform as the group continues to grow

·; Issued £107 million of privately placed notes announced on 8 August 2019 in two series (10 and 15 years' maturities) with a weighted average interest rate of 2.3%.

·; As at 30 September 2019 gross debt stood at £757 million with undrawn facilities of £250 million.

 

Results for the six months ended 30 September 2019 will be announced on 12 November 2019.

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFEEIILFIIA
Date   Source Headline
16th Jul 20187:00 amRNSScrip Dividend Declaration
12th Jul 20184:59 pmRNSPricing of £300m senior unsecured bond
10th Jul 20184:28 pmRNSResult of AGM
9th Jul 20182:49 pmRNSNotification of Major Interests in Shares
5th Jul 201810:35 amRNSPDMR notification
5th Jul 20187:00 amRNSTrading Update
4th Jul 20187:00 amRNSChairman Appointment
25th Jun 20184:10 pmRNSCommittee membership
21st Jun 20186:13 pmRNSScrip Calculation Price
7th Jun 20187:00 amRNSAnnual Report & Notice of AGM
7th Jun 20187:00 amRNSNotice of Dividend
1st Jun 201811:40 amRNSNotification of Transaction by PDMR
1st Jun 20187:00 amRNSAppointment of Non-Executive Director
23rd May 20187:00 amRNSAssura Full Year Results
16th May 20187:00 amRNSNotice of Results
27th Apr 20189:44 amRNSNotification of Major Interests in Shares
23rd Apr 20182:37 pmRNSNotification of Major Interests in Shares
23rd Apr 201812:22 pmRNSNotification of Transaction by PDMR
16th Apr 20187:25 amRNSScrip Dividend Declaration
5th Apr 20182:58 pmRNSNotification of Major Interests in Shares
3rd Apr 20187:00 amRNSDirectorate Change
22nd Mar 20183:05 pmRNSScrip Calculation Price
22nd Mar 20187:00 amRNSDirectorate Change
8th Mar 20182:28 pmRNSNotice of Dividend
22nd Feb 20181:16 pmRNSTotal Voting Rights
9th Feb 20181:28 pmRNSPDMR Notification
1st Feb 20187:00 amRNSTrading Update
15th Jan 20189:46 amRNSScrip Dividend Calculation
8th Jan 20183:59 pmRNSDebt redemption
21st Dec 20172:03 pmRNSNotification of Major Interests in Shares
21st Dec 201711:59 amRNSScrip Calculation Price
7th Dec 20174:59 pmRNSNotification of Major Interests in Shares
7th Dec 20174:56 pmRNSNotification of Major Interests in Shares
7th Dec 20173:11 pmRNSNotice of Dividend
7th Dec 201712:06 pmRNSNotification of Major Interests in Shares
7th Dec 201710:28 amRNSDirector/PDMR Shareholding
6th Dec 201710:17 amRNSNotification of Major Interests in Shares
4th Dec 201712:28 pmRNSResult of General Meeting
4th Dec 20177:00 amRNSResult of Proposed Share Issue
30th Nov 20175:29 pmRNSNotification of Major Interests in Shares
17th Nov 20177:00 amRNSCompletion of Bookbuild
16th Nov 20171:02 pmRNSPublication of Prospectus
16th Nov 20177:02 amRNSProposed Share Issue and Notice of GM
16th Nov 20177:00 amRNSInterim Results 2017
1st Nov 201711:24 amRNSTotal Voting Rights
20th Oct 201712:24 pmRNSNote issuance and increased debt facilities
18th Oct 201710:00 amRNSNotice of Results
16th Oct 20177:00 amRNSScrip Dividend Declaration
10th Oct 20177:00 amRNSAppointment of Non-Executive Director
3rd Oct 20173:01 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.